Hanni Kiiski is a PhD researcher in the Neural group in Trinity Centre for Bioengineering. Hanni’s research focuses on electrophysiological measures of.

Slides:



Advertisements
Similar presentations
Medical Biotechnology Regenerative Medicine
Advertisements

Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Informed Consent For Chemotherapy
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
REGENERATIVE MEDICINE
REGENERATION OF BONE TISSUE THROUGH STEM CELLS FOR THE TREATMENT OF OSTEOARTHRITIS Allen Wang and Sravan Rajathilak Arthritis Arthritis is a degenerative.
What is REGENERATIVE MEDICINE? “The regeneration or replacement of cells, tissues or organs to restore or establish normal function.” The goal is to.
Francine Goulet, Ph.D., pht Nanomedical Biological Device in Development for Torn ACL Replacement.
Peter F Scott School of Law & Social Science Glasgow Caledonian University.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
This presentation will provide a brief introduction into stem cell technology. I hope that you enjoy the lecture. There will be several quiz questions.
Stem Cell Therapy Briana Lolo. Statistics Coronary heart disease is the most common type of heart disease, killing more than 385,000 people annually.
CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,
Educell d.o.o. Cell Therapy Service Saša Puhar, M. Pharm., Spec. Educell Ltd., Ljubljana, Slovenia Ljubljana, 2009.
Figure 12, Greatly enhanced total calcium deposition on CAP modified nHA/Chitosan scaffold after 3 weeks of culture. Data are mean ±SEM; n=9. *p
Biomechanics and biology: bridging the gap Sam Evans School of Engineering
Funding Opportunities at the NIH and the National Institute of Biomedical Imaging and Bioengineering Grace C.Y. Peng, Ph.D. March 19, st annual ORNL.
Biomedical Research.
Cardiovascular Tissue Engineering Priya Ramaswami July 26, 2006 Department of Bioengineering, University of Pittsburgh McGowan Institute for Regenerative.
Section 1 Cell Differentiation and Proliferation.
Reviewed by: AGNES Purwidyantri D  To create products that improve tissue function or heal tissue defects.  Replace diseased or damaged tissue.
Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute.
Using Stem Cells to Treat Disease The first step: establish stem cell lines (large groups of the same cells) Next: turn on specific genes so that the stem.
Tissue Engineering The Growing Field of Cell Manufacturing Sierra Obi BME 181 February 24, 2013.
Regenerative Options for Knee Osteoarthritis Cellular Medicine Chris Evans PhD REHABILATATION MEDICINE RESEARCH CENTER.
Jasna Marinović, M.D., Ph.D. Associate Professor Department of Physiology.
Stem cell technologies Current state Future promise Where UCI fits in to the Post Prop. 71 world of biotechnology development in California.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Prof : Heba M Saad Eldien Manager Of Tissue Culture And Molecular Biology center Deputy director Of Genetic and metabolic disorders Lab Professor.
TEMPLATE DESIGN © Claire Brougham 1,2, Gerard M. Cooney 3, Thomas C. Flanagan 4, Stefan Jockenhoevel 5, Fergal J. O’Brien.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
EnvironmentScaffolds Stem Cells Tissue Engineering & Regenerative Medicine.
Interna tional Neurourology Journal 2016;20 Suppl 1:S23-29 Extracellular Matrix Revisited: Roles in Tissue Engineering Youhwan Kim 1, Hyojin Ko 1, Ik Keun.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
Katherine Bruce and Valerie Kristofic
Orthobiologics in sports medicine: an overview of the market
BIOMEDICAL ENGINEERING
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Equipment set-up for perfusion decellularization of whole kidney
Cartilage Growth . Alex Eddington, Nicholas Denney Design Concept
Jonathan Bomar1, Scott Collins Ph.D1,2, and Rosemary Smith Ph.D1,3
Cell Delivery Mechanisms for Tissue Repair
EXTRACELLULAR MATRIX COMPOSITION AND
Objectives Methods Results Conclusion
Regenerative Medicine
Wound Healing: A Paradigm for Regeneration
Ezzatollah Fathi1, Raheleh Farahzadi 2, *, Najmeh Sheikhzadeh3
UEMS Multi Joint Committee on Sports Medicine
Stem cells in dentistry – Part II: Clinical applications
Granulocyte macrophage – colony stimulating factor (GM-CSF) significantly enhances articular cartilage repair potential by microfracture  M.-D. Truong,
“Regenerative Medicine” Some success stories!
In Vitro Evaluation of a Rapidly In situ Forming Hyaluronic acid Hydrogel as a Carrier for Mesenchymal Stem Cell Delivery Elaheh Jooybar1*, Mohammad J.
M.H. Li, R. Xiao, J.B. Li, Q. Zhu  Osteoarthritis and Cartilage 
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells.
The trachea: The first tissue-engineered organ?
Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture  Dr R.L. Mauck, Ph.D., X. Yuan, Dr.
A.R. Gannon, T. Nagel, D.J. Kelly  Osteoarthritis and Cartilage 
Cell Delivery Mechanisms for Tissue Repair
LEARN ABOUT OUR PURPOSE & COMITTMENT TO IMPROVING PATIENT QUALITY OF LIFE Skye Biologics, a U.S.-based leader in biotechnology, was founded in 2006 to.
3D histopathological grading of osteochondral tissue using contrast-enhanced micro- computed tomography  H.J. Nieminen, H.K. Gahunia, K.P.H. Pritzker,
Engineering Stem Cell Organoids
Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells.
Retreat Topics iPSC Opportunities in NIAMS Diseases
Expression of the PTH/PTHrP receptor in chondrogenic cells during the repair of full- thickness defects of articular cartilage  H. Mizuta, M.D., Ph.D.,
E.B Hunziker, M.D., I.M.K Driesang, D.V.M. 
The changing role of the superficial region in determining the dynamic compressive properties of articular cartilage during postnatal development  A.R.
Hematology Journal Club
Repair of superficial osteochondral defects with an autologous scaffold-free cartilage construct in a caprine model: implantation method and short-term.
Claudia Loebel, Jason A. Burdick  Cell Stem Cell 
Presentation transcript:

Hanni Kiiski is a PhD researcher in the Neural group in Trinity Centre for Bioengineering. Hanni’s research focuses on electrophysiological measures of cognitive function in multiple sclerosis involving both cross-sectional and longitudinal studies. Since starting her PhD in 2010 on an IRCSET award, Hanni has published peer reviewed journal papers and presented her research at international and national conferences. "I truly enjoy my time in TCBE where I have excellent opportunities to learn and deepen my knowledge on Neural Engineering and related areas. Especially, I have been able to advance my research skills and acquire more information on my main interest, the cognitive functions in neurological conditions. The excellent contact network of TCBE has enabled my PhD project to involve close collaboration with experts in TCBE, Department of Neurology of St. Vincent's University Hospital, and School of Psychology in University College Dublin, and therefore provided an excellent working environment." My name is Eamon Sheehy and I am a final year PhD student in the Regenerative Medicine group. My research focuses on cartilage and bone tissue engineering applications and in particular how environmental cues can modulate the fate of mesenchymal stem cells for use in such applications. A major challenge in MSC- based cartilage repair therapies in the prevention of hypertrophy and terminal differentiation. Since bone is vascularised and cartilage is not the local oxygen environment may be a regulatory factor in determining MSC phenotype. The study below demonstrates that low oxygen conditioning of chondrogenically primed MSCs promotes a more stable chondrogenic phenotype whereas normoxic conditioning promotes a hypertrophic phenotype This has consequences for tissue engineering strategies when attempting to engineer grafts for either cartilage regeneration or bone regeneration via endochondral ossification. Stephen Sheridan is a PhD researcher in the Cardiovascular group and tells us of his goals. Tissue engineered arteries have the potential to be used as an alternative source to the limited available autologous bypass grafts. The objective of my research is to create such a tissue engineered artery, in a quick and efficient manner, using decellularized porcine tissue as a scaffold. Decellularization is the process of removing all the cellular components from a tissue which leaves a porous 3D architecture which is ideal for cell attachment and growth. The scaffold that remains consists of extracellular matrix, namely collagen and elastin, which offers ideal mechanical properties, similar to the native artery. The main limitation of this scaffold is its highly dense nature which to date has proved difficult to infiltrate with cells. I have developed customisation techniques which increase the porosity of the scaffold and create a means of directly injecting cells within the scaffold to produce a fully repopulated scaffold quickly without compromising its mechanical integrity. The long term goal of this research to produce a tissue engineered artery in vitro, created from a patients’ own cells that can be translated to a patient in a clinically feasible time frame.

PhD Student Alanna Gannon is researching the depth dependent properties of articular cartilage in the Regenerative Medicine Group. Alanna tells us of her research: Osteochondral sections stained with picrosirius red (for collagen) and safranin O (for proteoglycans) from the femoral trochlear ridge. The reason this histology was carried out was to look at the depth dependent structure of articular cartilage, specifically collagen and glycosaminoglycan content and structure and to correlate this to the tissues mechanical properties and its biochemical content. The objective of this study was to elucidate the role of the superficial region in determining the dynamic properties of articular cartilage. Specifically we have shown that removal of the superficial region will influence both the flow dependent and independent properties of articular cartilage, leading to a reduction the dynamic modulus of the tissue. My name is Tariq Mesallati, and I am a third year PhD student in the Regenerative Medicine group of the TCBE. I started my post-graduate research in October 2009, after receiving my B.A., B.A.I. in Mechanical Engineering from TCD. My research is focused on generating up-scaled cartilage grafts with clinically relevant dimensions suitable for treating large cartilage defects. Currently, the standard procedure for treating Osteoarthritis (OA) is total joint replacement, with the replacement joint degenerating over time. The aim of this study is to scale up current tissue engineering treatments to larger approaches to successfully engineer an anatomically accurate, osteochondral construct, which could potentially be used to treat OA. I am currently investigating the potential of using infrapatellar fat pad derived mesenchymal stem cells (FPSCs) to engineer the cartilaginous component of the osteochondral construct. This image is a close up shot of such engineered cartilage, formed using FPSCs self-assembled onto transwell inserts. My name is Michael Takaza, and I am a mature student doing a PhD at the Centre for Bioengineering. I started my PhD in September 2010, after receiving my B.Eng. from NUIG (National University of Ireland, Galway) and M.Sc. (Bioengineering) from Trinity College Dublin. I worked for Zerusa Medical (Now Vascular Solutions Galway) and Vivasure Medical in Galway before I came to Trinity to enrol for post-graduate full time studies. My PhD research work is on the microstructural characterisation of muscle tissue during external loading. Constitutive models of skeletal muscle tissue are vital tools in impact biomechanics, medical engineering, rehabilitation engineering and surgical simulation. For practical reasons most current models are derived from experimental work on animal tissue, but existing models are limited. My study aims to use experimental techniques to characterise the 3D mechanical behaviour of skeletal muscle. The limitations of our current understanding of how skeletal muscle behaves at a micro- structural level inhibit the proper development of skeletal muscle models with good predictive capabilities. After the completion of the 3D mechanical analysis of skeletal muscle (which will include detailed microscopic work), the aim is to develop a micro-structural based skeletal muscle model.